Rejected at 10:08 p.m. Mar, 12, 2024 ] by Cameron
Author: AbdelrahmanMahmoud
Related Note: 1523551767770 5
Rationale for change

Acceptable sources include:(Society guidelines (AAFP, USPSTF; website links must be provided)

https://www.aafp.org/pubs/afp/issues/2020/0201/p168.html

I check this website however it shows the 2017 IDSA guideline. There's is 2021 IDSA guideline as per uptodate

https://www.uptodate.com/contents/clostridioides-difficile-infection-in-adults-treatment-and-prevention

https://www.idsociety.org/practice-guideline/clostridioides-difficile-2021-focused-update

1. For patients with an initial CDI episode, we suggest using fidaxomicin rather than a standard course of vancomycin (conditional recommendation, moderate certainty of evidence). Comment: This recommendation places a high value in the beneficial effects and safety of fidaxomicin, but its implementation depends upon available resources. Vancomycin remains an acceptable alternative

I. In patients with recurrent CDI episodes, we suggest fidaxomicin (standard or extended-pulsed regimen) rather than a standard course of vancomycin (conditional recommendation, low certainty evidence)

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step2_v12::Original_decks::Zanki_Step_2::IM::GI_&_Nutrition #AK_Step2_v12::!Shelf::Surgery::no_dupes::only_step2 #AK_Step2_v12::!Shelf::FM::no_dupes::only_step2 #PANCE::EOR::EM #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#AMBOSS::rBafXM #AK_Step2_v12::Original_decks::Dorian::im::ome::gi::acute_diarrhea #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::02_Gram_Positive_Bacilli::Clostridium_Difficile #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::34_Pharmacology_Of_Bacterial_Infections_DNA_Replication_Transcription_and_Translation #AK_Step2_v12::#Resources_by_rotation::Surgery::amboss::dorian::gi #AK_Step2_v12::Original_decks::Dorian::surg::amboss::gi #AK_Step1_v12::#Pixorize::04_Microbiology::04_Bacteria-Gram_Positive::18_Clostridium_difficile #AK_Step3_v12::#UWorld::6233 #PANCE::EOR::Surgery #AK_Other::AnKing_Image::!Subjects::Microbiology::CDI_risk_and_management #AK_Step1_v12::#Pixorize::04_Microbiology::01_Antibiotics/Antiparasitics::26_Metronidazole #AK_Other::AnKing_Image::Mujeeb::CDI_risk_and_management #AK_Step1_v12::#UWorld::Step::10401 #AK_Step1_v12::#AMBOSS::jra_SN #AK_Step2_v12::#UWorld::Step::2022 #AK_Step1_v12::#OME_banner #AK_Step2_v12::#AMBOSS::_Ga5bm #AK_Step1_v12::#NinjaNerd::03_Microbiology::04_Pharmacology::03_Antibiotics #AK_Step2_v12::#B&B::06_GI::05_Other::01_Diarrhea #AK_Step2_v12::#Resources_by_rotation::IM::ome::gi::acute_diarrhea #AK_Step1_v12::#OME_banner::Clinical::03_Gastroenterology::07_Acute_Diarrhea #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::11_Glycopeptides_including_Vancomycin #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::15_Clostridia::01_Clostridium_tetani::*Clostridium_Difficile #AK_Step1_v12::#AMBOSS::y2ad4P #PANCE::GI::diarrhea #AK_Step2_v12::#OME::01_Medicine::03_Gastroenterology::07_Acute_Diarrhea #AK_Step1_v12::#UWorld::COMLEX::25482 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::05_Aminopenicillins #AK_Step1_v12::#Textbooks::#Mims_Microbiology::23_Gastrointestinal_Tract_Infections #AK_Step2_v12::Original_decks::Dorian::im::uw::gi #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::27_Empiric_Antibiotics_in_GI_Skin_Bone_and_Hematogenous_Infections #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::15_Clostridia #AK_Step2_v12::#Resources_by_rotation::IM::uw::gi_nutrition::gi_nutrition_dorian #AK_Step2_v12::#Resources_by_rotation::IM::uw::gi_nutrition::gi_nutrition_zanki #AK_Step2_v12::#Resources_by_rotation::FM::ome::gi::acute_diarrhea #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::Original_decks::Dorian::fam::ome::gi::acute_diarrhea #AK_Step1_v12::#Textbooks::#Cecil::98_Infectious_Diarrhea #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::1surgery #AK_Step1_v12::#Bootcamp::Microbiology::07_Clostridium::01_Clostridioides_Difficile #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step2_v12::#UWorld::Step::105704 #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::02_Gram_Positive_Bacilli::Clostridium_Difficile::Management #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::01_Antimicrobial_therapy::*Other_Antibiotics::Fidaxomicin #AK_Step2_v12::#UWorld::COMLEX::106695 #AK_Step1_v12::#SketchyMicro::uw_micro_(do_this_one_last) #AK_Step1_v12::#SketchyMicro::01_Bacteria::02_Gram_(+)_Bacilli::05_Clostridioides_difficile #AK_Step1_v12::#Textbooks::#Cecil::034_Common_Clinical_Manifestations_of_Gastrointestinal_Disease_Diarrhea #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::03_Clostridium_Difficile